Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia TOKY ...
GB News on MSN6h
Alzheimer's breakthrough: Scientists discover why women more at risk of developing dementia than menScientists have discovered why women are more at risk of developing dementia than men in a new breakthrough for Alzheimer’s ...
Hosted on MSN4h
Gamma stimulation for Alzheimer’s patients: 40-hertz sensory therapy shows tremendous promiseIn a nutshell Simple 40-hertz light and sound stimulation can induce brain rhythms that reduce Alzheimer’s pathology and ...
In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback